Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis
Konturek P, Zopf Y, Dieterich W, Wirtz S, Neurath M, Brzozowski T (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 12
Pages Range: S148-S148
DOI: 10.1093/ecco-jcc/jjx180.236
Authors with CRIS profile
Yurdagül Zopf
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Walburga Dieterich
Medizinische Fakultät
Stefan Wirtz
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Markus Neurath
Lehrstuhl für Innere Medizin I (Medizin 1)
Involved external institutions
Jagiellonian University / Uniwersytet Jagielloński (UJ)
Poland (PL)
Thüringen-Kliniken "Georgius Agricola"
Germany (DE)
Poland (PL)
Thüringen-Kliniken "Georgius Agricola"
Germany (DE)
How to cite
APA:
Konturek, P., Zopf, Y., Dieterich, W., Wirtz, S., Neurath, M., & Brzozowski, T. (2018). Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis. (pp. S148-S148).
MLA:
Konturek, P., et al. "Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis." 2018. S148-S148.
BibTeX: Download